ARCHIVES

Randomized Trials Discovered Roles For Newly Approved Nexavar and Sutent.

This article is from The Cancer Letter archive.

Vol. 32 No. 07 | February 24, 2006

Download PDF Visit The Full Archive

Related Articles

National Action Plan: Return $14 Million To NCI, Committee Tells Shalala

February 14, 1997

Lung Cancer Clinical Trials Cost-Effective Alternative

October 31, 2003

“Great Charlie Moertel Shootout: In Tucson Draws Laughs, Criticism

April 17, 1981

Study Links Breast, Pancreatic Cancer Risks to Lynch Syndrome

February 24, 2012

In Brief: Appropriations Markup Delayed Until September; FCRC Recompetition Draws 94 Requests for RFP

July 31, 1981

The Future of Cancer Centers: Demographics Informatics, Genetics, Will BE Major Influences, Robert Young Says

May 7, 1999